Dr. Jerry P. Weir,
Director of the Division of Viral Products (DVP), Office of Vaccines Research and Review with the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER)
Dr. Jerry P. Weir received his PhD in Biochemistry from Vanderbilt University and did postdoctoral research in virology at the National Institutes of Health. He joined the U.S. Food and Drug Administration (FDA) in 1994 and is currently the Director of the Division of Viral Products (DVP), Office of Vaccines Research and Review with the FDA’s Center for Biologics Evaluation and Research (CBER). In his position as Director of DVP, Dr. Weir manages the regulatory activities and research programs of the Division. As a Senior Investigator at CBER, he directs a research program pertaining to diverse viruses, including influenza, herpesviruses, and poxviruses. Dr. Weir frequently serves as an advisor to the World Health Organization on issues relating to influenza virus vaccines activities and vaccine standards.